Longitudinal study of risk factors predicting cannabis use disorder in UK young adults and adolescents
Abstract Background: Cannabis use disorder (CUD) affects up to 1 in 5 people who try cannabis. In order to develop…
Research Article
Willingness to use a drug checking service for cannabis and cannabis-based products: results from an online survey of people who regularly use cannabis in France
Abstract Introduction: As cannabis is illegal in France, there is no regulation of the quality or composition of cannabis products…
Immune cell exhaustion and apoptotic markers in major depressive disorder: Effects of in vitro cannabidiol administration
Abstract Background: Immune dysregulation is a component of Major Depressive Disorder (MDD). Cannabidiol (CBD) has immunomodulatory and putative antidepressant effects.…
Factors associated with cannabis use disorder among Australians using prescribed and illicitly-sourced medical cannabis
Abstract Background: People who use cannabis medically do so more frequently than those who use nonmedically, potentially placing them at…
Expanding the Therapeutic Profile of Topical Cannabidiol in Temporomandibular Disorders: Effects on Sleep Quality and Migraine Disability in Patients with Bruxism-Associated Muscle Pain
Abstract Background: Cannabidiol (CBD) has demonstrated potential as a therapeutic agent for muscle tension, pain, and sleep bruxism, yet its…
Characterization of the Volatile Compounds of the Hardwood Portion of Betula papyrifera Marshall From Quebec, Canada
Abstract Betula papyrifera Marshall (paper birch) hardwood is an abundant yet underutilized resource for Quebec’s forestry industry. We investigated the…
Medical and recreational cannabis use in patients undergoing one- or two-level lumbar spine fusion correlated with postoperative outcomes
Abstract Background: Cannabis use in the United States has become increasingly prevalent due to the legislation leading to decriminalization in…
Understanding motives for illicit medicinal cannabis use: an exploratory analysis in a medical cannabis program
Abstract Background: Medical Cannabis (MC) is authorized in numerous state-legislated programs to treat approved medical conditions. Notwithstanding MC access, some…
Sex differences in the capacity of minor phytocannabinoids to attenuate nociceptive insults in HIV-1 Tat-expressing mice
Abstract Objecives: Approximately 80 % of people living with HIV (PLWH) develop chronic pain and preclinical studies support the involvement…
Long‐term efficacy and safety of cannabidiol in patients with treatment‐resistant focal epilepsies treated in the Expanded Access Program
Abstract Objective: Cannabidiol (CBD) treatment was associated with long‐term seizure reduction in patients with various treatment‐resistant epilepsies who participated in…